The Seven is DexCom’s second generation device designed to help people with diabetes better manage their diabetes and control their glucose levels.
Terrance Gregg, president and CEO of DexCom, said: “We are pleased to have CE Mark approval for the Seven and we look forward to working with physicians, nurses and diabetes educators to bring this important technology to patients around the world. We hope to initiate a limited launch of Seven in Europe before the end of 2008 and a more robust launch in 2009.”